- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0001973

About Encyclia Pharmaceuticals Private Limited
Data last updated:
Encyclia Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the corporate training and development segment of the education sector. It was incorporated on 05 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U80100DL2012PTC244482. Its GSTIN is 07AADCE2147A1Z9 (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹18 Lakh. It was formerly known as Encyclia Private Limited and Excalibur Learning Private Limited. It is led by directors Atish Kumar and Koushlia Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, India – 110060.
As per the financials filed for FY 2024, the company reported a revenue of ₹10,000, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹13.91 Lakh and EBITDA of -₹5.69 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 72% over three years and 63% over five years.
As per MCA filings, the company has open charges of ₹20.2 Lakh and satisfied charges of ₹50 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.
Encyclia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0001973). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website exlp.net.
Company details
Name history
Encyclia Pharmaceuticals has undergone 4 name changes throughout its history. The current legal name is Encyclia Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Encyclia Pharmaceuticals Private Limited | Current |
| Encyclia Private Limited | Previous |
| Excalibur Learning Private Limited | Previous |
| Excalibur Infradevelopers Private Limited | Previous |
| Encyclia Global Private Limited | Previous |
CIN history
Encyclia Pharmaceuticals has one previous CIN (Corporate Identification Number): U45400DL2012PTC244482. The current CIN is U80100DL2012PTC244482, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U80100DL2012PTC244482 | Current |
| U45400DL2012PTC244482 | Previous |
Recognitions & Rankings of Encyclia Pharmaceuticals
Contact details
Encyclia Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is exlp.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, India – 110060
- IndustryEducation, Corporate Training & Development
To see the full contact details of Encyclia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Encyclia Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Encyclia Pharmaceuticals Private Limited, buy the company report.
Financials of Encyclia Pharmaceuticals Private Limited
FY 2025 filings availableEncyclia Pharmaceuticals Private Limited reported revenue of ₹10,000 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 63% over five years. EBITDA fell 168% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Encyclia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Encyclia Pharmaceuticals Private Limited
Encyclia Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koushlia Devi Also directs: Prakriti Pai Pai Nidhi Limited | Additional Director | 18 Aug 2023 | 3 Years 3 Months | Current |
| Atish Kumar Also directs: Encyclia Care Private Limited, Prakriti Pai Pai Nidhi Limited, Koshiv Enterprises Private Limited and 1 more | Director | 05 Nov 2012 | 14 Years 0 Months | Current |
Auditor
Encyclia Pharmaceuticals Private Limited is audited by ANKIT ANIL & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT ANIL & ASSOCIATES | FY 2019 | 026702N |
Shareholding
The shareholding of Encyclia Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Encyclia Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2019 | 100269635 | Others | ₹20.2 Lakh | Open | |
| 04 Mar 2013 | 10414977 | Punjab National Bank | ₹50 Lakh | Satisfied |
To see the full charge records of Encyclia Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Encyclia Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal miscellaneous application | Filed against the company by M/S Icici Bank Ltd | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Encyclia Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Encyclia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Encyclia Pharmaceuticals has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCE2147A1Z9 | Delhi | Active | 19 Aug 2017 |
| 07AADCE2147A2Z8 | Delhi | Active | 27 Jan 2020 |
| 09AADCE2147A2Z4 | Uttar Pradesh | Active | 12 Sep 2020 |
To see the full GST registrations and return filing status of Encyclia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Encyclia Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Adesh Kumar ceased to be Additional Director on 23 Aug 2023.
Frequently asked questions
Encyclia Pharmaceuticals is an active private limited company based in Delhi, India. The company works in corporate training and development, within the education industry. It was incorporated on 05 November 2012 (14+ years old) and is registered under CIN U80100DL2012PTC244482.
Encyclia Pharmaceuticals has 2 current directors:
- Koushlia Devi - Additional Director
- Atish Kumar - Director
The latest financial statements of Encyclia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Encyclia Pharmaceuticals is 07AADCE2147A1Z9, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AADCE2147A2Z8 (Delhi), 09AADCE2147A2Z4 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Encyclia Pharmaceuticals is U80100DL2012PTC244482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Encyclia Pharmaceuticals has 3 court cases on record: 3 filed against it.
Encyclia Pharmaceuticals was incorporated on 05 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Adesh Kumar ceased to be Additional Director on 23 Aug 2023. Koushlia Devi was appointed as Additional Director on 18 Aug 2023. Pramod ceased to be Director on 12 Dec 2019. Encyclia Pharmaceuticals has 4 board changes on record in total.
Yes, Encyclia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0001973).
Encyclia Pharmaceuticals can be reached through the website exlp.net. Its registered office is in Delhi, India.

